Chimeric Antigen Receptor T-Cell (CAR-T Cell) Therapy

An Indo–Singapore collaboration under the Technology Development Board has been initiated to develop CAR-T cell therapy for treating Multiple Myeloma, an incurable blood cancer.

About CAR-T Cell Therapy

Definition

CAR-T cell therapy is a form of advanced immunotherapy that uses a patient’s own immune cells to fight cancer.

It is often called a:

“living drug”

because it involves living, modified cells that continue to act inside the body.

What are T-Cells?

T-cells are a type of white blood cell in the immune system.

Function

• Identify abnormal cells

• Kill infected or cancerous cells

• Maintain immune defense

“T-cells are the body’s natural defence soldiers against disease.”

How CAR-T Cell Therapy Works

The process involves several steps:

1. Collection of T-Cells

• T-cells are extracted from the patient’s blood.

2. Genetic Modification in Laboratory

• A new gene is inserted into the T-cells

• This gene codes for a special receptor called:

Chimeric Antigen Receptor (CAR)

3. Formation of CAR-T Cells

• Modified T-cells become CAR-T cells

• These are engineered to target cancer cells specifically

4. Reinfusion into Patient

• CAR-T cells are infused back into the patient’s body

5. Cancer Cell Attack

CAR-T cells:

• Identify cancer cells using CAR receptors

• Bind to specific cancer antigens

• Destroy malignant cells

What are CARs (Chimeric Antigen Receptors)?

CARs are:

• Artificially engineered proteins

• Designed to recognize specific proteins on cancer cells

Function

They act as:

• “Targeting systems” for T-cells

allowing precise identification of cancer cells.

Target Disease: Multiple Myeloma

Multiple Myeloma is:

• A type of blood cancer

• Affects plasma cells in bone marrow

Nature

• Chronic and currently incurable

• Requires long-term management

Why CAR-T Therapy is Important

1. Personalized Treatment

• Uses patient’s own cells

• Reduces rejection risk

2. High Precision

• Targets only cancer cells

• Minimizes damage to healthy cells

3. Long-lasting Effect

• Modified cells can remain active in the body

4. Breakthrough in Cancer Treatment

Represents shift from:

• Conventional chemotherapy → targeted cellular therapy

Applications of CAR-T Therapy

Primarily used in:

• Blood cancers

• Leukemia

• Lymphoma

• Multiple myeloma

Advantages of CAR-T Cell Therapy

1. Targeted Action

• Highly specific to cancer cells

2. Reduced Side Effects

• Less damage to healthy tissues compared to chemotherapy

3. Advanced Immunotherapy

• Enhances natural immune response

4. Potential for Cure in Some Cases

• Especially in relapsed blood cancers

Challenges of CAR-T Therapy

1. High Cost

• Extremely expensive treatment

2. Side Effects

• Cytokine release syndrome (CRS)

• Neurological complications

3. Complex Manufacturing

• Requires advanced laboratory facilities

4. Limited Accessibility

• Mostly available in developed healthcare systems

India’s Role and Collaboration

India is collaborating with Singapore under Indo–Singapore scientific cooperation framework to:

• Develop indigenous CAR-T therapies

• Reduce treatment cost

• Improve cancer care access

Significance for India

1. Affordable Cancer Treatment

• Local production can reduce costs significantly

2. Strengthening Biotech Ecosystem

• Boosts cell and gene therapy research

3. Medical Innovation

• Advances precision medicine capabilities

4. Healthcare Sovereignty

• Reduces dependence on imported therapies

Future Potential

CAR-T therapy may expand into:

• Solid tumors (currently challenging area)

• Personalized cancer vaccines

• Combined immunotherapy approaches

Conclusion

CAR-T cell therapy represents a major breakthrough in modern oncology by transforming a patient’s own immune system into a targeted cancer-fighting tool. The Indo–Singapore collaboration led by the Technology Development Board reflects a significant step toward affordable and advanced cancer treatment in India, particularly for complex diseases like Multiple Myeloma.